NAFLD as a driver of chronic kidney disease
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide public health problems, affecting up to 25 –30% (NAFLD), and up to 10–15% (CKD) of the general population. Recently, it has also been established that there is a strong association between NAFLD and CKD, regardless of the presence of potential confounding diseases such as obesity, hypertension and type 2 diabetes. Since NAFLD and CKD are both common diseases that often occur alongside other metabolic conditions, such as type 2 diabetes or metabolic syndrome, elucidating the relative impact of NAFLD on the risk of incident CKD presents a substantial challenge for investigators working in this research field.
HIGH blood pressure is often branded the "silent killer" because its effects are not immediately perceptible to the eye but it can lead to life-threatening complications. The surest way to reduce high blood pressure is to add certain ingredients to your meals, including an Asian staple
The FDA advises against metformin use in hepatic impairment because of the risk of inducing lactic acidosis. Is this warning warranted?Alimentary Pharmacology &Therapeutics
CONCLUSIONS These results indicate that GDLP against T2DM-induced hepatic steatosis, oxidative stress, and inflammation by improving the Nrf2/HO-1 signaling pathway in db/db mice, suggesting the GDLP may serve as an effective strategy for in fatty liver treatment. PMID: 32245940 [PubMed - as supplied by publisher]
Conclusions: Craniomaxillofacial metastases, usually with multiple visceral or axial skeleton lesions, have an ominous prognosis. Multidisciplinary management could benefit the patient status and lead to more favourable outcomes. There are exceptional cases of long-term survival.RESUMEN Objetivo: Estudio descriptivo retrospectivo de 21 casos de met ástasis en tejidos blandos orales y/o huesos maxilares. Material y métodos: Revisión a 12 años de actas de nuestro departamento, excluyendo procesos linfoproliferativos, metástasis cutáneas, glándulas salivales, otros huesos crane...
Publication date: Available online 4 April 2020Source: Journal of Ayurveda and Integrative MedicineAuthor(s): Naresh Kumar P, Ragavendrasamy Balakrishnan, Vibhas Kana
Barbados on Sunday reported its first death from the new coronavirus after an 81-year-old man with diabetes died from pneumonia, the country's health minister said.
AbstractPurposeWe investigated the etiology and impact on outcomes of polycystic kidney disease in patients with abdominal aortic aneurysm.MethodsEight-hundred patients who underwent open (n = 603) or endovascular aortic repair (n = 197) were divided into three groups: no cyst (n = 204), non-polycystic kidney (n = 503), and polycystic kidney (≥ 5 cysts in the bilateral kidneys,n = 93). The characteristics and outcomes were compared among the groups.ResultsIn the polycystic kidney group, the age was increased and the proportions of patients with...
TYPE 2 diabetes requires one to lead a healthy lifestyle to keep blood sugar levels under control. Since exercise plays a key role in controlling blood sugar levels, the current lockdown poses a threat to type 2 diabetes management. Luckily, there is a simple activity you can do from the comfort of your home that has proven to lower post-meal blood sugar levels.
Pancreatic cancer researchers uncover worrying results in mice suggesting that hydroxychloroquine might be fatally toxic for people taking metformin for diabetes.
Abstract Lipoprotein (a) [Lp(a)] is an independent but moderate, predictor for coronary heart disease (CHD) prevalence and severity. Several established and emerging cardiovascular (CV) risk factors including age, gender, ethnicity, smoking, dyslipidemia, hypertension, obesity, type 2 diabetes mellitus, alcohol consumption, arterial stiffness and hyperuricemia have been linked to Lp(a) metabolism. Apart from CHD, Lp(a) has been also associated with non-cardiac vascular diseases and diseases associated with increased CV risk such as chronic kidney disease, metabolic syndrome, non-alcoholic fatty liver disease, erec...
More News: Alcoholism | Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Hypertension | International Medicine & Public Health | Liver | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Urology & Nephrology